0 Items
Select Page

Flavivirus Receptors

The Native Antigen Company manufacturers highly purified virus-host cell receptors using state-of-the-art expression and purification techniques. On request we can also undertake custom preparation of recombinant and native proteins for a broad range of disease states.

Flavivirus Receptors Background

Viruses are obligate intracellular pathogens and consequently need to gain entry into a host cell for completion of their life cycle. In order to enter to a cell, viruses attach to specific receptor molecules on the cell surface; molecules which also play an important role in normal cell function. Different viruses have evolved complex mechanisms to bind to these membrane-associated proteins and gain access to the cell interior.

Flaviviridae are small enveloped positive strand RNA viruses of an approximate diameter of 50 nm, which replicate in the cytoplasm of their respective host cell. The flavivirus family includes many mosquito-borne viruses, including Dengue virus (DENV), Yellow fever virus (YFV), West-Nile virus (WNV), Japanese encephalitis virus (JEV), Zika virus (ZIKV) and tick-borne encephalitis virus (TBEV), as well as blood-borne hepatitis C virus (HCV) (Knipe & Howley, 2013).

Flaviviruses enter cells by interaction of their E glycoprotein with cell surface receptors; these allow the virions to absorb onto the cell surface and enter the cells through receptor-mediated endocytosis. Secondary receptors may also be utilised to puncture the membrane or for fusion with the host cell. A specific receptor for internalization of flaviviruses into host cells has not yet been identified. It is believed that flaviviruses make initial contact with the host cell by binding to glycosaminoglycans (GAGs), such as heparan-sulfate proteoglycans or syndecans. However, the identity of the cellular receptors that mediate flavivirus entry and infection is still poorly known. A large number of attachment molecules such as DC-SIGN have been described as flavivirus candidate receptors in different cell types, but their precise role in virus endocytosis remains obscure. The best-characterized candidate proteins to date are C-type lectin receptors (CLEC5A) and the phosphatidylserine receptors, T-cell immunoglobulin and mucin domain (TIM) and TYRO3, AXL and MER (TAM) (Perera-Lecoin, et al., 2014; Laureti, et al., 2018).

Therefore, the E protein and its putative receptor and attachment molecules make promising targets for the design of antivirals and vaccine development.

References

Knipe, D. M. & Howley, P., 2013. Fields Virology. Sixth ed. s.l.:LWW.

Laureti, M., Narayanan, D. & et al., 2018. Flavivirus Receptors: Diversity, Identity, and Cell Entry. Front Immunol., Volume 9, p. 2180.

Perera-Lecoin, M., Meertens, L. & et al., 2014. Flavivirus Entry Receptors: An Update. Viruses, 6(1), p. 69–88.

Flavivirus Receptors

We offer a range of flavivirus receptors comprising highly purified recombinant proteins known to bind to a broad spectrum of viruses.

 

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Zika Prevalence in Suriname – an insight into assay cross-reactivity

A recent study published by Langerak et al tested for the seroprevalence of Zika virus in Suriname populations and evaluated the comparative effectiveness of using a commercial ELISA and a standard Virus Neutralisation Assay. Here we discuss the study, its results,...

What should you call your favourite virus?

The International Committee on Taxonomy of Viruses (ICTV) meet regularly to ensure the taxonomy of viruses is kept logical and up-to-date in the face of an ever-increasing number of new viruses and genome sequences; discussed in here in Nature. This sometimes results...

Overcoming Zika-Dengue cross-reactivity: the highly specific immunoassays your lab needs

In the global battle against Zika virus, serological cross-reactivity with Dengue is a major challenge for academics, epidemiologists and pharmaceutical companies alike. Novel immunoassays can now overcome this problem and could prove a real game-changer in Zika...

The Right Tools for Rubella

Rubella remains a significant pathogen worldwide, with 100,000 cases of congenital rubella syndrome estimated to occur every year. Vaccines to Rubella are highly safe and have effectively eliminated endemic infection in many developed countries, yet inadequate...

Visualising viral infection with immunofluorescence microscopy

Following the latest immunofluoresence data for our Zika and Dengue antibodies, we’ve invited VRS to write a short blog one of their areas of expertise: The applications of immunofluorescence microscopy in studying viruses.   A lot of what we know about biology...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

6 + 7 =

Live Customer Feedback